Let’s build on our strengths by prioritizing innovation that serves patients first: modern methods that reflect human biology ...
A federal agency that promised to scale back animal testing has quietly funded dozens of research projects, including one ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
The National Institutes of Health recently announced it is pivoting from using just animals in medical research, creating ...
Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...
Recent years have seen a growing movement away from animal testing and toward models that more closely replicate human physiology. This shift aims to protect animal welfare while concurrently ...
The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...
In a significant shift, the US Food and Drug Administration (FDA) has announced its plan to reduce its reliance on animal testing for drug development. This is especially for monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback